Skip to main content
Now entering pilot – 2027

The workflow engine for scalable concussion recovery.

Oculabs® gives providers and athletic trainers a connected platform to operationalize the standard of care — from baseline through return to activity — without the manual burden.

~3.8M
Concussions estimated annually in the U.S.
~34K
Athletic programs, clinics & institutions in our target market
$296M
Addressable U.S. concussion workflow market (2026 SAM)
The Problem

The standard of care exists. Executing it at scale doesn’t.

Concussion protocols are comprehensive and evidence-backed. But for providers and athletic trainers they’re manual, fragmented, and operationally expensive. Patients fall through the cracks. Progression decisions are harder to defend. Follow-up billing goes uncaptured.

01 — Injury
No Continuity
Patient seen once, then released into a paper-based or disconnected follow-up process.
02 — Recovery
Fragmented Signals
Symptoms, cognitive scores, and results tracked across separate tools — or not at all.
03 — Decision
Ambiguous Progression
Providers lack a defensible, structured basis for return-to-activity decisions.
04 — Outcome
Lost Revenue & Risk
Patients drop out. Billable follow-up goes uncaptured. Liability exposure increases.
The Platform

One connected recovery workflow.

Oculabs® combines a provider web platform with a patient mobile app to operationalize the full concussion recovery cycle — configurable workflows, decision support, and longitudinal tracking built in.

⚙️

Configurable Workflows

Organizations define their own care protocols — assessments, sequence, and responsible roles.

🚦

Decision Support

Signals become flags. Flags inform progression. Providers retain full clinical control.

🔗

Signal Ingestion

Ingest results from existing tools. Oculabs® consolidates without replacing.

“Assessment tools measure a moment. Oculabs® manages recovery over time.”

organization.oculabs.com/dashboard
Oculabs provider dashboard
Who We Serve

Built for the providers who manage recovery every day.

🏟

Athletic Trainers & Athletics Programs

High school programs, NCAA institutions, and professional organizations managing concussion protocols across large athlete populations.

23,500+ high school programs1,064 NCAA institutions197 pro teams
🧠

Concussion Clinics & Sports Medicine

Specialty clinics and sports medicine providers who need scalable, structured follow-up without adding staff.

685+ concussion clinics7,800+ sports neurology practices

Interested in piloting Oculabs®?

We’re actively recruiting athletic programs and concussion clinics for our pilot cohort.

Our Products

Two connected apps. One recovery workflow.

A provider web platform and patient mobile app designed to operationalize concussion recovery — from first baseline to return-to-activity.

The Platform

Built around how recovery actually works.

Most concussion tools focus on a single moment — the assessment. Oculabs® is built around what comes after: the longitudinal recovery workflow that providers struggle to execute consistently at scale.

Our platform connects modular assessments, configurable workflows, external signal ingestion, and decision support into one unified system.

“Standardize care without forcing sameness.”

organization.oculabs.com/patients/details
Oculabs patient detail view
For Providers

The Oculabs® Provider Web Platform

A clinical operations dashboard giving providers full visibility into every patient’s recovery — across events, assessments, and time.

🗂️

Longitudinal Patient Records

Every baseline, post-injury event, follow-up, and assessment in one organized timeline.

⚙️

Configurable Workflow Builder

Define your protocol — assessments, sequence, role assignments, and follow-up cadence.

🚦

Decision Support & Flags

Configurable rules evaluate signals and surface flags — so providers know who needs attention.

🏢

Enterprise Org Management

Hierarchy-based RBAC and multi-tenant architecture for complex healthcare organizations.

🔔

Automated Follow-Up

Scheduled reminders reduce administrative burden and dramatically lower patient dropout rates.

🔗

External Signal Ingestion

Ingest scores from tools your team already uses. Consolidate without replacing.

For Patients & Athletes
Oculabs mobile app

The Oculabs® Patient Mobile App

A recovery companion that keeps patients engaged, connected, and on track — between visits, at home, and on the sideline.

Remote check-ins and assessments

Complete assigned protocols from anywhere on iPhone.

Recovery progress visibility

Athletes see exactly where they are in the return-to-activity process.

Notification-driven follow-up

Automated reminders keep patients engaged without requiring provider action.

HIPAA-compliant, AWS-hosted

Encrypted data, secure authentication, healthcare-grade privacy controls.

Assessment Library

Modular assessments. Your protocols.

Oculabs® decomposes established concussion standards into reusable modules — so organizations assemble the exact protocol that reflects their standard of care.

SCAT5
Sport Concussion Assessment Tool — global standard for sideline and clinical evaluation.
Child-SCAT5
Age-appropriate assessment for pediatric athletes ages 5–12.
SCOAT6
Comprehensive in-office assessment for sub-acute and ongoing evaluation.
VOMS
Vestibular/Ocular Motor Screening — validated ocular and vestibular symptom assessment.
MACE
Military Acute Concussion Evaluation — sideline and point-of-care settings.
External Signals
Ingest result scores from proprietary tools. Oculabs® consolidates, not replaces.
Decision Support Engine

Signals → Flags → Progression.

Configurable rules evaluate signals and surface guidance — alerting providers to stalled recovery, concerning trends, or patients ready to progress — without replacing clinical judgment.

Step 1 — Collect

Signals collected

Symptom scores, cognitive results, external tool data, patient self-report

Step 2 — Evaluate

Rules evaluated

Admin-configured thresholds determine which flags are raised

Step 3 — Guide

Progression guidance surfaced

Provider sees: Not Progressing · Needs Review · Ready to Progress

Stalled recovery alertsSymptom threshold flagsVOMS concern flagsProgression guidanceMissed check-in alertsCognitive score review

“Decision support should not replace clinical judgment. It should make judgment scalable and more defensible.”

See Oculabs® in action.

Request a walkthrough with our clinical and product team.

Who We Serve

Built for the people managing concussion recovery every day.

Purpose-built for the institutions and providers responsible for athlete and patient safety.

Primary Market

Athletic Trainers & Athletics Programs

Athletic trainers are the frontline of concussion care in American sports — managing high patient volumes with limited tools. Oculabs® gives them the operational infrastructure to run compliant, consistent protocols across every athlete.

From baseline management to return-to-play progression, Oculabs® turns scattered protocols into one connected workflow.

23,519 high school programs1,064 NCAA institutions197 professional teams
organization.oculabs.com/roster
Oculabs roster view

Baseline Management at Scale

Automated scheduling, completion tracking, and organized historical records across entire rosters.

Sideline & Post-Injury Workflows

Structured post-injury events with modular assessments reflecting your program’s chosen protocol.

Return-to-Play Decision Support

Configurable progression logic — defensible, documented, and consistent return-to-play decisions.

Secondary Market
Oculabs mobile app

Concussion Clinics & Sports Medicine Practices

Specialty clinics deal with the same operational challenge: high-touch, fragmented follow-up that’s hard to execute consistently and even harder to scale.

Oculabs® turns episodic visits into structured, longitudinal recovery programs — more touchpoints, better documentation, stronger case for reimbursable engagement.

685+ concussion clinics7,856 sports neurology practices672 performance clinics

Structured Follow-Up Without More Staff

Automated check-ins and remote assessments keep patients engaged between visits.

Better Economics, Better Care

Build a structured follow-up cadence that can support ongoing, potentially reimbursable recovery engagement.

The Difference

What changes when Oculabs® is in the workflow.

✗ Without Oculabs®
Manual tracking across paper, spreadsheets, and disconnected tools
Patients disappear after the first visit
Follow-up reminders fall to clinical staff
Progression decisions without structured signal review
No longitudinal record to defend return-to-activity choices
✓ With Oculabs®
One connected platform from baseline to return-to-activity
Automated check-ins keep patients engaged between visits
Providers notified when signals warrant attention
Progression guidance backed by documented signal history
Structured follow-up that can support reimbursable engagement

Interested in a pilot for your organization?

We’re actively recruiting programs and clinics for our 2025–2026 pilot cohort.

Who We Are

A team built to bring clinical rigor to operational reality.

Neuroscience Innovations is the company behind Oculabs® — clinicians, technologists, and commercialization leaders building the infrastructure concussion care has always needed.

Our Mission

Operationalize the standard.
Improve the outcome.

The evidence-based standard for concussion recovery exists. The problem isn’t the standard — it’s the infrastructure to execute it consistently at scale.

Neuroscience Innovations is building that infrastructure. Oculabs® is our first product, focused on the $296M U.S. concussion workflow market.

“Big category. Narrow wedge. Realistic plan.”

🎯

Mission

Build technology that makes neurocognitive care easier to deliver, more consistent, and more defensible for every provider at every scale.

🔭

Vision

Become the workflow and decision support platform for neurocognitive care — starting with concussion, expanding across the spectrum of brain health management.

Leadership

The team behind the platform.

MV
Mitchell Vander Vegt
Co-founder & Chief Executive Officer
Mitchell co-founded Neuroscience Innovations with the conviction that the concussion care ecosystem needed better workflow infrastructure, not just better tests. He leads operations, product, and technology.
CP
Christina Pohl, PhD, ATC
Co-founder & Chief Science Officer
Tina brings certified athletic trainer credentials and clinical expertise to the platform, ensuring Oculabs® reflects how concussion care is actually practiced in the field.
AH
Ashlee Horn
Co-Founder & Chief Strategy Officer
Ashlee brings B2B SaaS commercialization experience, PE-backed growth exposure, and a neuroscience background (University of Miami). She leads go-to-market strategy and pilot execution.
Market Opportunity

Big category. Narrow wedge. Realistic plan.

We’re starting where our clinical insight is deepest, buyer pain is clearest, and path to commercialization is most defined.

2026 TAM — Neurocognitive Digital Care
~$40.7B
U.S. neurocognitive digital care platforms
2026 SAM — Concussion Workflow Buyers
~$296M
Athletic programs, clinics & sports medicine
Target SOM — 2027 Commercial Launch
$281K → $5M+
ARR from 2027–2031 (mean scenario)
For Investors

We’re building Oculabs® to last.

📋

Real Platform

Oculabs® isn’t a prototype. Provider web app and patient mobile app are built on production-grade AWS with HIPAA-ready architecture.

🏁

Commercialization-Ready Team

With Ashlee Horn’s addition as CSO, the team now has the GTM discipline needed to move from product to revenue.

📈

Defined Path Forward

Pilot partnerships → commercialization 2027 → horizontal platform expansion. Capital funds execution, not discovery.

Interested in learning more?

Reach out for investor materials or a platform walkthrough.

Contact Us

Let’s talk.

Whether you’re an investor, a potential pilot partner, a healthcare organization, or a reporter — we’d love to hear from you.

Send us a message.

This form is managed by Squarespace. We respond within 1–2 business days.

By submitting you agree to our Privacy Policy.

🤝

Pilot Partners

We’re actively recruiting athletic programs and concussion clinics for our pilot cohort. Reach out to learn about early access.

📈

Investors

Oculabs® is seeking strategic investment. Use this form to request our investor materials.

📰

Press & Media

For press inquiries, please include your outlet and deadline and we’ll respond promptly.

Support

We’re here to help.

Oculabs® is currently in active pilot development. If you’re part of a pilot program or working with our team, reach out below.

📬

Pilot Partner Support

If you’re part of an active pilot program, your Oculabs® point of contact is your primary resource. You can also email our team directly.

Email
📱

Patient App Support

If you’re a patient using the Oculabs® mobile app, please contact the provider or athletic trainer who enrolled you first — or email us directly.

Email

Full provider documentation, a self-serve help center, and in-app support resources are in development ahead of commercial launch.

— Oculabs® Team
From Oculabs

Insights on concussion care, and neurocognitive health.

Oculabs® is currently in active pilot development. If you’re part of a pilot program or working with our team, reach out below.

Featured
Clinical Insight
Why Concussion Recovery Is a Workflow Problem, Not Just an Assessment Problem

The evidence base for concussion care is stronger than ever. So why are providers still struggling with inconsistent outcomes? The answer isn’t better tests — it’s better infrastructure.

[ Image ]
Recent Posts
🧠
March 2026 · Clinical Insight
SCAT5 vs. SCOAT6: Understanding the Role of Each Standard in a Comprehensive Concussion Protocol
Both tools are validated. Both have a role. Here’s how providers can think about using them together — and what a modular approach looks like in practice.
📈
February 2026 · Market Perspective
The $296M Market That’s Still Running on Spreadsheets
Athletic trainers and concussion clinics manage complex, high-stakes recovery workflows with tools built for a different era.
🏟
January 2026 · Athletics
Return-to-Play Decisions Are High Stakes. Here’s How Better Decision Support Changes the Picture.
Premature return to play is one of the highest-risk outcomes in sports medicine. Most programs lack the infrastructure to apply the standard consistently.
🏢
December 2025 · Company News
Oculabs® Welcomes Ashlee Horn as Co-Founder and Chief Strategy Officer
Ashlee brings B2B SaaS commercialization experience, a neuroscience background, and a direct connection to athlete safety.
Clinical Insight

Why Concussion Recovery Is a Workflow Problem, Not Just an Assessment Problem

Oculabs® Editorial Team · April 2026 · 5 min read

The evidence base for concussion care has never been stronger. Yet providers and athletic trainers continue to struggle with inconsistent outcomes, high patient dropout between visits, and progression decisions that feel more like guesswork than clinical judgment.

The answer isn’t better tests. It’s better infrastructure.

The Assessment Is Not the Bottleneck

SCAT5, VOMS, SCOAT6, and MACE are all clinically validated. The problem isn’t that providers don’t know what to measure — it’s what happens after the measurement. Assessment results get recorded on paper, in a spreadsheet, or in a general-purpose EHR not designed for longitudinal concussion tracking.

What a Workflow Problem Actually Looks Like

Athletic trainers managing rosters of 50, 100, or 200 athletes can’t chase down every overdue check-in manually. Concussion clinic providers can’t hold in their heads the full recovery arc of every patient they’ve seen in the past three months.

The Infrastructure Layer That’s Missing

Oculabs® is designed to be the layer between the assessment and the decision. It ingests signals from established tools, organizes them into a longitudinal record, evaluates them against configurable clinical rules, and surfaces actionable flags and progression guidance.

Assessment tools measure a moment. Oculabs® manages recovery over time.

Clinical Insight

SCAT5 vs. SCOAT6: Understanding the Role of Each Standard

Oculabs® Editorial Team · March 2026 · 6 min read

Both SCAT5 and SCOAT6 are validated tools for concussion assessment. Both have a role in a comprehensive protocol. Yet many providers treat them as interchangeable — or use only one because “that’s what we’ve always done.”

SCAT5: The Global Sideline Standard

The Sport Concussion Assessment Tool 5th Edition is the most widely recognized sideline assessment tool globally. It combines symptom evaluation, standardized cognitive testing, and neurological screening in a single instrument designed for use within minutes of a suspected concussion.

SCOAT6: The In-Office Evolution

The Sport Concussion Office Assessment Tool 6th Edition is designed for sub-acute evaluation — the clinic visit that happens days to weeks after the initial injury. It goes deeper into symptom characterization, cognitive testing, and ocular/vestibular screening than is practical on a sideline.

Why Modularity Matters

Oculabs® decomposes both tools into reusable assessment modules — so organizations assemble the exact protocol that reflects their standard of care.

Market Perspective

The $296M Market That’s Still Running on Spreadsheets

Oculabs® Editorial Team · February 2026 · 4 min read

More than 23,000 high school athletic programs, 1,064 NCAA institutions, and hundreds of concussion specialty clinics in the United States are responsible for managing concussion recovery — and the vast majority are doing it with paper forms, general-purpose spreadsheets, and disconnected point solutions.

Why the Market Is Primed for Change

Three forces are converging: increasing regulatory and liability pressure on return-to-play decisions, growing clinical consensus around structured protocols, and the proven viability of digital health platforms for longitudinal patient monitoring.

Athletics

Return-to-Play Decisions Are High Stakes. Here’s How Better Decision Support Changes the Picture.

Oculabs® Editorial Team · January 2026 · 5 min read

Premature return to play following a concussion is one of the highest-risk outcomes in sports medicine. Yet for most programs, those decisions are made with incomplete signal data, manual tracking, and no documented progression history to reference or defend.

Configurable Rules, Defensible Decisions

Oculabs®’s decision support engine lets organizations configure progression rules based on their own standard of care — so that return-to-play decisions are not only clinically sound but also systematically documented.

Company News

Oculabs® Welcomes Ashlee Horn as Co-Founder and Chief Strategy Officer

Oculabs® Team · December 2025 · 3 min read

Neuroscience Innovations is pleased to announce that Ashlee Horn has joined the company as Co-Founder and Chief Strategy Officer. Ashlee brings a rare combination of B2B SaaS commercialization leadership, PE-backed growth experience, and a neuroscience background from the University of Miami.

What Ashlee Brings to Oculabs®

Ashlee’s role is focused on translating Oculabs®’s product and clinical foundation into commercial traction — building the go-to-market strategy, piloting the commercialization model with early partners, and strengthening investor relationships.

Careers

Build the infrastructure for better concussion care.

Oculabs® is a small, focused team working on a real clinical problem with a real platform. We’re not a big company — but we’re building something that matters.

Why Oculabs

Meaningful work. Real ownership. Early stage.

We’re building Oculabs® at the intersection of clinical science and healthcare operations. The technical challenges are real, the market is large, and the impact on patient outcomes is direct.

We’re pre-revenue — early team members get meaningful ownership and outsized influence over product direction.

🤱
Real product problems

Modular assessment architecture, configurable workflow engines, decision support systems.

🏥
Healthcare that matters

Our platform helps providers make better, faster, more defensible decisions for patients recovering from brain injuries.

📍
Remote-friendly

We’re a distributed team. We care about outcomes, not offices.

Open Roles
Engineering
Full-Stack Software Engineer
Remote · Full-time
Clinical
Clinical Advisor / ATC Consultant
Remote · Contract / Advisory
General Interest
Don’t see your role? Reach out anyway.
We’re always interested in great people.
Engineering

Full-Stack Software Engineer

Remote · Full-time
Colorado Springs, CO (HQ)
$110K – $145K

About Oculabs®

Neuroscience Innovations is building Oculabs® — a provider web platform and patient mobile app that operationalizes concussion recovery workflows. We’re pre-revenue, product-ready, and entering our pilot phase.

The Role

We’re looking for a full-stack engineer who can own both the provider web application and the patient mobile app, contribute to platform architecture decisions, and work directly with clinical and product stakeholders.

What You’ll Work On

  • Modular assessment framework (SCAT5, VOMS, SCOAT6 decomposed into configurable modules)
  • Configurable workflow engine — rules-driven workflow builder
  • Decision support system — signal evaluation, flag generation, progression guidance
  • Provider dashboard — patient queue management, notification system
  • Patient mobile app (iOS/React Native) — remote check-in flows, progress visibility
  • AWS infrastructure — Elastic Beanstalk, ALBs, CloudFront, Route 53

What We’re Looking For

  • 3+ years full-stack experience (React, Node.js or equivalent backend)
  • Experience with iOS development (Swift or React Native)
  • Comfort with AWS infrastructure and HIPAA-compliant architecture
  • Strong communication skills — you’ll work closely with clinical stakeholders
  • Self-directed — we’re a small team and you need to own your work

Compensation & Benefits

  • Salary: $110,000 – $145,000 (commensurate with experience)
  • Meaningful early-stage equity package
  • Remote-first, flexible working hours
  • Direct influence over product and technical direction

How to Apply

Send your resume and a brief note about why you’re interested in Oculabs® to:

info@neuroscienceinnovations.com

Subject line: Full-Stack Engineer Application — [Your Name]. We respond within 5–7 business days.

Apply via Email
Clinical

Clinical Advisor / ATC Consultant

Remote · Contract / Advisory
Competitive hourly / equity

About Oculabs®

Neuroscience Innovations is building Oculabs® — a concussion recovery workflow platform for athletic trainers and healthcare providers. Clinical accuracy is foundational to everything we build.

The Role

We’re looking for a certified Athletic Trainer (ATC) or sports medicine clinician to serve as a part-time clinical advisor. Flexible hours, primarily remote, with occasional virtual collaboration sessions.

What You’ll Do

  • Review and validate assessment module content for clinical accuracy (SCAT5, Child-SCAT5, VOMS, SCOAT6, MACE)
  • Provide input on workflow design — how protocols are actually executed in field and clinic settings
  • Review progression logic and flag rules for clinical appropriateness
  • Participate in user testing with early pilot partners

What We’re Looking For

  • Current ATC certification (BOC) or licensed sports medicine clinician
  • Direct experience managing concussion protocols in an athletic program or clinical setting
  • Familiarity with SCAT5, VOMS, and/or SCOAT6
  • Clear, direct communication style

Compensation

  • Hourly consulting rate (negotiable based on experience)
  • Equity consideration available for longer-term advisory arrangements
  • Flexible time commitment — typically 4–8 hours/month

How to Apply

Send your CV and a brief description of your clinical background to:

info@neuroscienceinnovations.com

Subject line: Clinical Advisor Application — [Your Name].

Apply via Email